- Home
- CC vs DNTH Comparison
CC vs DNTH Comparison
Compare CC & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CC | DNTH |
|---|---|---|
| Founded | 2014 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 4.5B |
| IPO Year | 2014 | 2018 |
Fundamental Metrics
Financial Performance| Metric | CC | DNTH |
|---|---|---|
| Price | $21.17 | $90.86 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 13 |
| Target Price | $20.11 | ★ $121.00 |
| AVG Volume (30 Days) | ★ 2.0M | 1.0M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.33% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $6,638,000,000.00 | $2,036,000.00 |
| Revenue This Year | $6.15 | N/A |
| Revenue Next Year | $5.95 | $29.48 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 7.36 | N/A |
| 52 Week Low | $10.44 | $18.08 |
| 52 Week High | $28.67 | $96.50 |
Technical Indicators
Market Signals| Indicator | CC | DNTH |
|---|---|---|
| Relative Strength Index (RSI) | 44.27 | 58.62 |
| Support Level | $20.22 | $79.27 |
| Resistance Level | $21.85 | $92.41 |
| Average True Range (ATR) | 1.13 | 5.38 |
| MACD | -0.02 | 0.93 |
| Stochastic Oscillator | 41.33 | 88.61 |
Price Performance
Historical ComparisonAbout CC Chemours Company (The)
The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, paints and coatings, plastics, transportation, semiconductor, and others. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.